Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Low-molecular-weight heparin : A review of the results of recent studies of the treatment of venous thromboembolism and unstable angina.

× No keyword cloud information.

10 in total

1. A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease.

Authors: S Husted; R Becker; A Kher
Journal: Clin Cardiol Date: 2001-07 Impact factor: 2.882

2. Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction.

Authors: John A. Ambrose; Zaheed Tai
Journal: Curr Treat Options Cardiovasc Med Date: 2002-02

3. Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes. A Canadian hospital perspective.

Authors: R M Balen; C A Marra; P J Zed; M Cohen; L Frighetto
Journal: Pharmacoeconomics Date: 1999-11 Impact factor: 4.981

4. Economic evaluation of enoxaparin sodium versus heparin in unstable angina. A French sub-study of the ESSENCE trial.

Authors: B Detournay; X Huet; F Fagnani; G Montalescot
Journal: Pharmacoeconomics Date: 2000-07 Impact factor: 4.981

Review 5. Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors: in the management of acute coronary syndromes.

Authors: Nick Bosanquet; Bengt Jönsson; Keith A A Fox
Journal: Pharmacoeconomics Date: 2003 Impact factor: 4.981

6. Comparison of Time to Therapeutic aPTT in Patients Who Received Continuous Unfractionated Heparin After Implementation of Pharmacy-wide Intervention Alerts.

Authors: Duaa Alsulaiman; Katelyn Sylvester; Craig Stevens; Danielle Carter
Journal: Hosp Pharm Date: 2016-09

Review 7. Blood thinners and gastrointestinal endoscopy.

Authors: Monjur Ahmed
Journal: World J Gastrointest Endosc Date: 2016-09-16

Review 8. New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism.

Authors: Joo Hee Kim; Kyung-Min Lim; Hye Sun Gwak
Journal: Biomol Ther (Seoul) Date: 2017-09-01 Impact factor: 4.634

Review 9. Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants.

Authors: Osamu Kumano; Kohei Akatsuchi; Jean Amiral
Journal: Biomedicines Date: 2021-03-07

10. Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo.

Authors: P Mellor; J R Harvey; K J Murphy; D Pye; G O'Boyle; T W J Lennard; J A Kirby; S Ali
Journal: Br J Cancer Date: 2007-08-28 Impact factor: 7.640

10 in total